Need for longitudinal studies to assess the real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma - Authors´ reply
Lancet Reg Health Eur
.
2022 Apr 21:17:100388.
doi: 10.1016/j.lanepe.2022.100388.
eCollection 2022 Jun.
Authors
Benedikt Fritzsching
1
,
Marco Contoli
2
,
Celeste Porsbjerg
3
,
Sarah Buchs
4
,
Julie Rask Larsen
5
,
Lisa Elliott
4
,
Mercedes Romano
4
,
Nick Freemantle
6
Affiliations
1
Paediatric Pulmonology and Allergy, Children's Doctor Service, Heidelberg, Germany.
2
Respiratory Section, Department of Translational Medicine, University of Ferrara, Italy.
3
Department of Respiratory Medicine, Bispebjerg Hospital, University of Copenhagen, Denmark.
4
Global Market Access, ALK-Abelló, Denmark.
5
Global Medical Affairs, ALK-Abelló, Denmark.
6
Institute of Clinical Trials and Methodology, University College London, UK.
PMID:
35494214
PMCID:
PMC9046862
DOI:
10.1016/j.lanepe.2022.100388
No abstract available